Clinical Trial Update: A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma [Phase 4]

View source ↗

Summary

Clinical trial update for decitabine in relapse and refractory diffuse large B cell lymphoma (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Mingzhi Zhang | Conditions: Diffuse Large B Cell Lymphoma | Phase 4 | Status: UNKNOWN